Clinical Trial Update: The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

An early-phase Phase 1/2 trial investigating a three-drug combination (adebrelimab, apatinib, and liposomal irinotecan) as second-line therapy for gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Xianglin Yuan | Conditions: Advanced Gastric Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING